Johnson & Johnson to Seek F.D.A. Authorization for Booster Shot

The request, expected this week, comes after a study found the company’s vaccine was only 71 percent effective against hospitalization from Covid-19.

Johnson & Johnson to Seek F.D.A. Authorization for Booster Shot

The request, expected this week, comes after a study found the company’s vaccine was only 71 percent effective against hospitalization from Covid-19.

Opinion | Was the Decision on Boosters Bungled?

Readers discuss the government’s handling of the issue. Also: Abortion stories; criminal justice reform; voice recognition; extinct species.

U.S. Coronavirus Death Toll Surpasses 700,000 Despite Wide Availability of Vaccines

The latest Covid-19 deaths were concentrated in the South, and included more younger people than before. Every age group under 55 saw its highest death toll of the pandemic this August.

Opinion | ‘The Moratorium Saved Us. It Really Did.’

With the eviction moratorium over, the road to more opportunity and less inequality runs through affordable housing.

Youth Vaping Declined Sharply for Second Year, New Data Show

Now that it has stopped selling most flavored pods, Juul has become far less popular with teens than brands offering disposable fruit- and candy-flavored devices.

States Begin a Complex Booster Shot Rollout for Pfizer Recipients

Health officials were preparing on Friday to start giving booster shots to older and at-risk Americans, trying to make sense of new and broad eligibility guidelines.

Opinion | New Guidance on Booster Shots Gets Ahead of the Science

The responsibility for making decisions about getting boosters in some cases has shifted onto individuals and their doctors.

Biden Promised to Follow the Science. But Sometimes, He Gets Ahead of the Experts.

White House officials dismiss criticism that President Biden’s comments on booster shots amount to undue pressure on public health experts.

States Begin a Complex Booster Shot Rollout for Pfizer Recipients

Health officials were preparing on Friday to start giving booster shots to older and at-risk Americans, trying to make sense of new and broad eligibility guidelines.

Biden Promised to Follow the Science. But Sometimes, He Gets Ahead of the Experts.

White House officials dismiss criticism that President Biden’s comments on booster shots amount to undue pressure on public health experts.

C.D.C. Chief Overrules Agency Panel and Recommends Pfizer-BioNTech Boosters for Workers at Risk

In a highly unusual decision, the C.D.C. director, Rochelle Walensky, reversed a move by agency advisers and endorsed additional doses of the Pfizer-BioNTech vaccine for health care workers, teachers and other workers at risk.

Federal Panel Recommends Booster Shots, Opening New Campaign Against the Virus

Scientific advisers to the C.D.C. endorsed additional doses of the Pfizer-BioNTech vaccine for older Americans but not for health care workers, in a possible rift with regulators.

Boosters for Moderna and Johnson & Johnson vaccine recipients weren’t up for debate during a C.D.C. panel.

The panel was not asked to judge whether people who received the Moderna and Johnson & Johnson vaccines should receive Pfizer-BioNTech boosters.

Fighting a Pandemic, While Launching Africa’s Health Revolution

Public health in Africa has been a story of neglect and dependency, says John Nkengasong, the first director of the Africa Centers for Disease Control. But he’s on a mission to turn things around.

F.D.A. Advisory Panel Recommends Pfizer Boosters for Older People and Others at High Risk

The committee said there was insufficient evidence to recommend third shots for all adult recipients of the vaccine, as Pfizer had requested.

Hours before the F.D.A. vote, the C.D.C. released a study showing waning protection of the Pfizer vaccine.

The study found that the shots’ effectiveness in preventing hospitalization fell to 77 percent from 91 percent four months after full vaccination.

It’s That Time of Year, Experts Warn: Get a Flu Shot

Public health experts recommend an annual flu shot, and are worried a “twindemic” with Covid-19 could further burden health care facilities this year.

U.S. Booster Policy Is in Flux as Studies Add to Dissent

A week before President Biden’s plan is to roll out, scientists are at odds about whether extra coronavirus shots are needed and for whom.

Unwilling to Wait for Approval, Some Healthy Americans Seek Booster Shots

Many who feel they need more coronavirus protection have managed to obtain an extra dose. “I did feel bad about it. But I didn’t feel bad enough,” one woman said.